Runway Backslide: Plus‑Size Models Vanish Amid Weight‑Loss Drug Craze

Here’s a breakdown of the provided text, focusing on its main points and themes:

Main Topic: The evolving beauty standards in fashion, especially considering weight loss drugs and a growing push for inclusivity.

Key Arguments/Points:

* Risks of Weight Loss Drugs: Dr. Lash warns against using weight loss drugs without medical supervision, emphasizing potential side effects and the danger of using them for purely aesthetic reasons. He stresses these drugs are not without consequences (“There’s no such thing as a free lunch”).
* Fashion’s Past Narrowness: Fashion has historically promoted an unrealistic and frequently enough unhealthy body ideal (size 0).
* Increased Stakes with Weight Loss Drugs: The accessibility of weight loss medication raises the stakes,possibly reinforcing harmful beauty standards.
* demand for Inclusivity: Industry experts (burns and White) argue that fashion brands are missing out by alienating plus-size consumers, who have significant purchasing power across various luxury goods.
* Normalization of Diverse Bodies: The call for a more inclusive portrayal of bodies on runways and in marketing is emphasized. It shouldn’t be a “conversation” but a “normalization.”
* Ester Manas as an Example: The Ester Manas fall-Winter 2023 collection is highlighted as a positive example of size diversity, with their show notes stating, “everybody is invited.”

Overall Theme: The article advocates for a more inclusive and realistic representation of beauty in the fashion industry,cautioning against the dangers of pursuing unrealistic body standards,especially with the aid of potentially harmful medications. It suggests that brands should embrace and cater to a wider range of body types, recognizing the economic power and inherent worth of all consumers.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.